16.3: Regulation of the Citric Acid Cycle

Search Fundamentals of Biochemistry

Learning Goals 

(Learning goals written by Claude, Sonnet 4.6, Anthropic)

Regulation of the Pyruvate Dehydrogenase Complex

• Describe the allosteric regulation of the pyruvate dehydrogenase complex (PDC) by its substrates (pyruvate, NAD⁺, CoASH as activators) and products (acetyl-CoA, NADH, ATP as inhibitors), and explain how these signals reflect the energy and carbon status of the mitochondrial matrix.
• Explain the covalent regulation of the PDC by pyruvate dehydrogenase kinase (PDK) and pyruvate dehydrogenase phosphatase (PDP), identifying the three serine phosphorylation sites on the E1 α subunit, explaining the molecular basis by which phosphorylation inhibits TPP binding and lipoyl domain interaction, and describing the activators and inhibitors of PDK (including the therapeutic use of dichloroacetate).
• Connect PDC regulation to hormonal signaling by explaining how insulin promotes PDC activation through dephosphorylation, while starvation and diabetes increase PDK-mediated phosphorylation and impair glucose oxidation, and why PDC deficiency presents with lactic acidosis after carbohydrate-rich meals.

Regulation of Key Citric Acid Cycle Enzymes

• Identify the three enzymes of the citric acid cycle that are primary regulatory targets (citrate synthase, isocitrate dehydrogenase, and α-ketoglutarate dehydrogenase), explain why their large negative ΔG°′ values make them ideal control points, and describe the common theme that the NADH/NAD⁺ and ATP/ADP ratios serve as master regulators of all three.
• Describe the allosteric regulation of citrate synthase — including inhibition by NADH, citrate (competitive with oxaloacetate), and succinyl-CoA (competitive with acetyl-CoA) — and connect the open-to-closed conformational change induced by oxaloacetate binding to the prevention of spurious acetyl-CoA hydrolysis.
• Explain the synergistic allosteric activation of isocitrate dehydrogenase by citrate and ADP, describing the molecular mechanism by which citrate binding to the γ regulatory subunit induces conformational changes that convert the active site from an inactive to an active conformation, and how ADP stabilizes citrate binding without causing further conformational change.
• Describe the regulation of α-ketoglutarate dehydrogenase by product inhibition (succinyl-CoA at E2, NADH), ATP/ADP ratio, and Ca²⁺ activation, drawing the explicit mechanistic parallel to PDC regulation and explaining why Ca²⁺ activation of this and the other dehydrogenases couples mitochondrial energy production to cellular signaling events.

Metabolon Formation and Substrate Channeling

• Explain how the assembly of citrate synthase, malate dehydrogenase, and aconitase into a metabolon enhances citric acid cycle flux through substrate channeling, and describe the electrostatic basis of the malate dehydrogenase–citrate synthase interaction — including the roles of Arg65, Arg67, and the open/closed conformational states of citrate synthase — and explain why direct channeling of oxaloacetate is especially important given its low steady-state concentration and the thermodynamically unfavorable malate dehydrogenase reaction.

Overview

The entry of pyruvate into the citric acid cycle, which leads to the aerobic production of energy and biosynthetic intermediates, is a key metabolic step. Hence, both the pyruvate dehydrogenase complex and key enzymes in the cycle are targets for regulation. This occurs through substrate availability, product inhibition, allosteric effectors, and post-translational modifications of key enzymes in the pathway. Figure \(\PageIndex{1}\) shows a summary figure of key regulators.

Figure \(\PageIndex{1}\): Regulation of the citric acid cycle

https://www.nature.com/articles/s41598-021-98314-z

Note that the key steps are primarily regulated by the mitochondrial NAD⁺/NADH ratio, which is strongly influenced by the ATP/ADP ratio. High NADH inhibits the regulatory enzymes. High levels of acetyl-CoA, derived from pyruvate dehydrogenase and also through fatty acid catabolism, increase flux through the cycle, in part by allosterically activating the first enzyme in the pathway, citrate synthase.

The material below is derived from Renée LeClair, Ph.D., Cell Biology, Genetics, and Biochemistry for Pre-Clinical Students. https://med.libretexts.org/@go/page/37584. openly licensed (CC BY-NC-SA 4.0

Regulation of the pyruvate dehydrogenase complex (PDC)

Under aerobic conditions, the pyruvate produced by glycolysis will be oxidized to acetyl-CoA using the pyruvate dehydrogenase complex (PDC) in the mitochondria (note: its genes are encoded in the nucleus). As this enzyme is a key transition point (the gatekeeper) between cytosolic and mitochondrial metabolism and is highly exergonic (ΔG^0' = -7.9 kcal/mol, -38 kJ/mol), it is highly regulated by both covalent and allosteric regulation. Deficiencies of the PDC are X-linked and present with symptoms of lactic acidosis after consuming a meal high in carbohydrates. This metabolic deficiency can be overcome by delivering a ketogenic diet and bypassing glycolysis altogether.

The PDC is regulated allosterically and covalently. The complex itself can be allosterically activated by pyruvate and NAD⁺. Elevation of the substrate (pyruvate) will enhance flux through this enzyme, as will the indication of low-energy states triggered by high NAD⁺ levels. The PDC is also inhibited by acetyl-CoA and NADH directly. Product inhibition is a common regulatory mechanism, and high NADH levels signal sufficient energy, thereby decreasing PDC activity. Figure \(\PageIndex{2}\) summarizes the regulation. (Adapted from Marks’ Medical Biochemistry)

Figure \(\PageIndex{2}\): Regulation of pyruvate dehydrogenase.

The PDC is also regulated through covalent modification. Phosphorylation of the complex's E1 subunits decreases the enzyme's activity.

The enzyme responsible for phosphorylating PDC is pyruvate dehydrogenase kinase. The kinase is regulated inversely to the PDC, as shown in Figure 1 above. The kinase is most active when acetyl-CoA, NADH, and ATP are high. These compounds will stimulate the kinase to phosphorylate and inactivate the PDC. Dichloroacetate, TPP, Ca²⁺, and pyruvate inhibit PDK. A calcium-mediated phosphatase, PDP, can dephosphorylate the PDC. Starvation and diabetes increase phosphorylation and inhibit the complex, impairing glucose oxidation.

Phosphorylation occurs on Serine 264 of the α subunit (site 1), Ser271 (site 2), and Ser203 (site 3), which are located on a conserved phosphorylation loop. Sites 1 and 2 (in loop A) stabilize TPP in the active site, while Ser 203 in the adjacent loop B binds Mg^2+, stabilizing PP on bound TPP. Inhibition requires phosphorylation of just one of the Ser side chains. Phosphorylation prevents the ordering of the loop that occurs on TPP binding, which hinders the binding of the lipoyl domains of the PDC core to E1p, which inhibits the flow of metabolites in the PDC.

The specific PDK inhibitor dichloroacetate prevents PDC phosphorylation, thereby increasing mitochondrial reactive oxygen species levels. This promotes the expression of a mitochondrial K⁺-channel axis, leading to cellular apoptosis and inhibition of tumor growth.

Figure \(\PageIndex{3}\) shows a summary of pathway regulation.

Figure \(\PageIndex{3}\): Summary of the regulation of pyruvate dehydrogenase

In general, PDC is activated through its substrates CoASH and NAD⁺, and kinase inhibition or phosphatase activation (PDP) (dichloroacetate, TPP, Ca²⁺, and pyruvate) is inhibited by its products, acetyl-CoA and NADH, as well as activation of the kinase (PDK). Abbreviations : PDC: pyruvate dehydrogenase complex, PDK: pyruvate dehydrogenase kinase, PDP: pyruvate dehydrogenase phosphatase, TPP: thiamine pyrophosphate.

The complex is also acetylated and succinylated.

Here is a brief review of general hormonal effects leading up to acetyl-CoA production:

Under low serum glucose conditions

• glucagon is secreted.  This activates glucose synthesis and glycogen breakdown, while inhibiting glycolysis in the liver.  Glucose is then exported into the blood, restoring a higher glucose concentration.

Under high serum glucose

• Insulin is secreted, promoting glucose uptake in the liver and muscle for energy use (glycolysis is activated, gluconeogenesis is inhibited) and storage (glycogen synthase is activated).

Table \(\PageIndex{1}\) below shows a summary of the regulation of pyruvate in glycolysis and pyruvate dehydrogenase, and also shows the effect of insulin. Glucagon leads to phosphorylation and inactivation of the designated enzymes, the opposite effect of insulin.

Metabolic Pathway	Major Regulatory Enzyme(s)	Allosteric Effectors	Post-translational modifications	Hormonal Effects
Glycolysis	hexokinase; glucokinase (liver)	Glucose 6P (-)
	PFK-1	Fructose 2,6BP, AMP (+) Citrate (-)		↑ Insulin leads to dephosphorylation of PFK2 and increases production of F2,6BP, which activates PFK-1
	Pyruvate Kinase (PK)	Fructose 1,6BP (+) ATP, Alanine (-)		↑ Insulin leads to dephosphorylation and activation of PK
Pyruvate Dehydrogenase Complex	PDC	Pyruvate, NAD^+ (+) Acetyl CoA, NADH, ATP (-)	dephosphorylation by PDP (+) phosphorylation by PDK (-)	↑ Insulin leads to dephosphorylation and activation of PDC

Table \(\PageIndex{1}\): Summary of the regulation of pyruvate through glycolytic enzymes and pyruvate dehydrogenase

Now, let's focus directly on the regulation of enzymes in the citric acid cycle.

Regulation of Citrate Synthase

Citrate synthase (ΔG^o = -7.5 kcal/mol, -31 kJ/mol), Isocitrate dehydrogenase (ΔG^o = -2.0 kcal/mol, -8.4 kJ/mol), and alpha-ketoglutarate dehydrogenase (ΔG^o = -7.2 kcal/mol, -30 kJ/mol) are all exergonic and likely candidates for regulation. Indeed, they are. Let's start with citrate synthase.

Citrate synthase is regulated in part by the availability of substrate acetyl-CoA and oxaloacetate. It is inhibited by NADH and citrate, a competitive inhibitor of oxaloacetate binding. Succinyl-CoA, a downstream product of the citric acid cycle, is a competitive inhibitor of acetyl-CoA binding.

Figure \(\PageIndex{4}\) shows an interactive iCn3D model of a structural comparison of pig citrate synthase with bound citrate (1CTS) and with bound citrate and CoASH (2CTS)

Figure \(\PageIndex{4}\): Structural comparison of pig citrate synthase with bound citrate (1CTS) and with bound citrate and CoASH (2CTS). (Copyright; author via source). Click the image for a popup or use this external link: https://structure.ncbi.nlm.nih.gov/i...94UeRDsFyGTcdA

Toggle the "a" key back and forth to change from the open structure (gray) with bound citrate (1CTS) to the closed structure (cyan) after CoASH binds (2CTS).

Citrate and CoASH are the products of the citrate synthase reaction, but observing how they interact with the protein gives clues into catalysis. When both are bound, the enzyme is in a closed conformation, which prevents spurious hydrolysis of the actual acetyl-CoA during the reaction that proceeds to citrate formation. In the presence of citrate, the enzyme is in open form, allowing the release of citrate as a product. The binding of the reactant oxaloacetate triggers the conversion to the closed form. NADH is reported to be an allosteric inhibitor of bacterial citrate synthases, but no entries are available for binding NADH to mammalian enzymes.

The effects of binding acetyl-CoA on the structure of citrate synthase are shown in Figure \(\PageIndex{5}\):

Figure \(\PageIndex{5}\): Effect of acetyl-CoA binding on CS structure. Omini, J., Wojciechowska, I., Skirycz, A. et al. The association of the malate dehydrogenase-citrate synthase metabolon is modulated by intermediates of the Krebs tricarboxylic acid cycle. Sci Rep 11, 18770 (2021). https://doi.org/10.1038/s41598-021-98314-z. Creative Commons Attribution 4.0 International License. http://creativecommons.org/licenses/by/4.0/.

Panel (A) shows the open conformation of CS (PDB ID 1cts) as a cartoon model, with cylindrical α-helices containing a citrate molecule represented as a stick. Subunits A and B are colored white and cyan, respectively. The side chains of the key residues A266Lys, A46Arg, and B164Arg are shown in sticks. The residues are shown in the order of the chain name, residue number, and amino acid. The dimeric structure was generated using crystallographic symmetry. One active site domain composed mainly of the A-chain is shown.

Panel (B) shows the superimposed model between the open (1cts; white) and closed (2cts; wheat) formats. The citrate molecule is at the same location with a slight rotation. The CoA molecule is present only in the closed format. The molecular domain shown can be divided into a movable upper half and a rigid lower half. In the bottom domain, A45Arg and B146Arg are shown in the stick model. The locations of those two Cα in Arg are almost consistent between the open and closed formats. The top half of the domain is movable. The motion is visible as the rotation of α-helices represented by A312Gly and A365Gly, indicated by arrows. The A366Lys moves inward and forms a hydrogen bond network A366Lys (NZ):: A438COA(O8A):: B164Arg(NH1).

Panel (C) shows the closed format of CS (PDB ID, 2cts) with citrate and CoA molecules in stick models.

Panel (D) shows the surface electrostatic potential of the open-format CS, excluding ligands. Calculations were performed in a vacuum environment, with values ranging from -71 to +71. Red and blue represent negative and positive potentials, respectively. The domain shown corresponds to panel A. Patches of negative charge (NC) and hydrophobic area (HF) are observed.

Panel (E) shows the surface electrostatic potential of the closed-format CS, excluding ligands. The domain shown corresponds to panel D. Patches of positive charge (PC1, PC2) are observed.

At the end of this chapter, we will see how citrate synthase's electrostatic surface potential enables it to interact with other enzymes in the citric acid cycle to form a metabolon.

Regulation of Isocitrate Dehydrogenase

In the previous section, structures of the αγ and αβ heterodimer building blocks of the protein were described. The α subunits contain the catalytic site, while the β and γ subunits are the regulatory subunits that bind allosteric effectors. Citrate and ADP allosterically activate both the α₂βγ heterotetramer and αγ heterodimer. They bind next to each other in the allosteric site, along with Mg²⁺. Conformational changes in binding citrate lead to a change in the activation of the catalytic subunit α. The binding of ADP enhances this effect.

The domain and cartoon structure of the αγ heterodimer of human NAD-IDH are shown in Figure \(\PageIndex{6}\).

Figure \(\PageIndex{6}\): Domain and cartoon structure of the αγ heterodimer of human NAD-IDH. Ma, T., Peng, Y., Huang, W. et al. Molecular mechanism of the allosteric regulation of the αγ heterodimer of human NAD-dependent isocitrate dehydrogenase. Sci Rep 7, 40921 (2017). https://doi.org/10.1038/srep40921. Creative Commons Attribution 4.0 International License. http://creativecommons.org/licenses/by/4.0/

The top panel shows the domain structure of the two monomers. The bottom panel shows two views of the dimer. The color coding is the same as in the top panel.

Figure \(\PageIndex{7}\) shows bound citrate and ADP in the allosteric binding site in the γ subunit of IDH.

Figure \(\PageIndex{7}\): Bound citrate and ADP in the allosteric binding site in the γ subunit of IDH. Ma et al., ibid.

The color represents the site's electrostatic surface potential, with blue indicating a more positive potential and red indicating a more negative potential. Note that both allosteric activators bind adjacent to each other. The binding of ADP does not change the conformation after the citrate is bound.

The proposed molecular mechanism for allosteric regulation of IDH is shown in Figure \(\PageIndex{8}\).

Figure \(\PageIndex{8}\): Mechanism of allosteric regulation of the αγ heterodimer of IDH. Ma et al., ibid.

Legend: In the absence of activators, the active site adopts an inactive conformation unfavorable for ICT binding, and the enzyme is in the basal state with a high S_0.5,ICT, and a low catalytic efficiency. The binding of CIT induces conformational changes at the allosteric site, which are transmitted to the active site through conformational changes of the structural elements at the heterodimer interface, including the β5–β6 loop, the α7 helix, and the β7-strand in both the α and γ subunits, leading to the conversion of the active site from the inactive conformation to the active conformation favorable for the ICT binding. Hence, the enzyme assumes a partially activated state, with a moderately decreased S_{0.5, ICT}  (the substrate concentration for half-maximal activity), and a moderately increased catalytic efficiency. The binding of ADP in the presence of CIT does not induce further conformational changes at the allosteric and active sites. Still, it establishes a more extensive hydrogen-bonding network among CIT, ADP, and surrounding residues via the metal ion, thereby enhancing or stabilizing CIT binding. Hence, the binding of CIT and ADP together has a synergistic activation effect, and the enzyme assumes the fully activated state with a substantially decreased S_0.5,ICT, and a significantly increased catalytic efficiency.

Regulation of α-ketoglutarate dehydrogenase

α-ketoglutarate dehydrogenase and the pyruvate dehydrogenase complex both catalyze the oxidative decarboxylation of α-ketoacids. They employ a common mechanism involving three enzymes, E1, E2, and E3, in a large complex. The regulation of α-ketoglutarate dehydrogenase activity is shown in Figure \(\PageIndex{9}\).

Figure \(\PageIndex{9}\): Regulation mechanisms of α-ketoglutarate dehydrogenase complex (α-KGDC). Vatrinet, R., Leone, G., De Luise, M. et al. The α-ketoglutarate dehydrogenase complex in cancer metabolic plasticity. LS and DHLA are lipoamide and dihydrolipoamide, respectively. TPP is thiamine pyrophosphate. Cancer Metab 5, 3 (2017). https://doi.org/10.1186/s40170-017-0165-0. Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/),

As with the other key regulatory enzymes, α-KGDC is regulated by the ratios of ATP/ADP and NADH/NAD⁺. The product, succinyl-CoA, inhibits the reaction at the E2 stage. Mitochondria are reservoirs of Ca²⁺ ions. These ions increase the activity of pyruvate, isocitrate, and α-ketoglutarate dehydrogenases, with α-ketoglutarate dehydrogenase being the most affected. Calcium effects also depend on ATP/ADP and NADH/NAD⁺ ratios.

Regulation by Metabolon Formation

Several citric acid cycle enzymes interact to form a metabolon, which enhances flux through pathways by channeling substrates and products directly from one enzyme to another within the complex. This "facilitated" diffusion minimizes substrate/product dissociation and enhances catalysis. Three enzymes in the citric acid cycle —citrate synthase, malate dehydrogenase, and aconitase —form a metabolon, as demonstrated by chemical cross-linking and docking studies. The link between malate dehydrogenase, which produces oxaloacetate, and citrate synthase, which utilizes it, is important because oxaloacetate concentrations are low and would otherwise reduce flux in the citric acid cycle if it were not channeled directly into citrate synthase. Malate dehydrogenase is also not favored to produce oxaloacetate based on standard free energy and K_eq values, so pulling the reaction towards citrate synthase in the metabolon also helps the flux.

L-malate+ NAD⁺ ↔ oxaloacetate + NADH + H⁺ ΔG^o = +7.1 kcal/mol (+30 kJ/mol)

Figure \(\PageIndex{10}\) shows models of malate dehydrogenase (MDH) and the open and closed forms of citrate synthase (CS). Electrostatic interactions are key.

Figure \(\PageIndex{10}\): Models of malate dehydrogenase (MDH) and the open and closed forms of citrate synthase (CS). Omini, J., Wojciechowska, I., Skirycz, A. et al. Association of the malate dehydrogenase-citrate synthase metabolon is modulated by intermediates of the Krebs tricarboxylic acid cycle. Sci Rep 11, 18770 (2021). https://doi.org/10.1038/s41598-021-98314-z. http://creativecommons.org/licenses/by/4.0/.Creative Commons Attribution 4.0 International License.

Panels (F) and (G) show simulated interactions between MDH (green) and CS in its open (white) form (panel F) and between MDH (green) and CS in its closed (wheat) format (panel G). The 65Arg and 67Arg residues involved in the MDH-CS interaction are highlighted in blue. Active site residues His274 and His320 (blue) and Asp375 (red) were shown.

Panel (H) Predicted acetyl-CoA binding sites in CS apoenzyme. The white surface model of the CS apoenzyme is shown in the open format. The 274His, 320His, 65Arg, and 67Arg residues are highlighted in blue. The orange mesh indicates the positions of acetyl-CoA at the predicted binding sites. White and orange stick models indicate the citrate and CoA in the reported crystal structure.

Does the activity of citrate synthase change when it is complexed to malate dehydrogenase in a metabolon? The results of studies probing that question show that it is affected. The results of such studies show that it does, as illustrated in Figure \(\PageIndex{11}\).

Figure \(\PageIndex{11}\): Effects of metabolites involved in the MDH and CS reactions on the affinity of the MDH-CS multi-enzyme complex. Omini et al., ibid.

Curves represent the response (fraction bound) against CS concentration (M). The interaction was assessed in the MST buffer (control, green) or in the presence of 10 mM of metabolites. Error bars represent the standard deviations of three measurements. Asterisks indicate the conditions that showed significant K_d differences with no K_d confidence overlap with the control.

Panel (A) shows the effects of the reaction substrates of MDH and CS. The MDH-CS interaction was assessed in the presence of acetyl-CoA (red), NAD⁺ (blue), or malate (brown).

Panel (B) shows the effects of the reaction on CS and MDH products. The MDH-CS interaction was assessed in the presence of CoA (grey), NADH (orange), or citrate (green).

Panel (C) shows the effects of oxaloacetate (OAA) in combination with other CS substrates. The effects of sole substrates, acetyl-CoA (red), OAA (blue), and NADH (orange), as well as their combinations, OAA/acetyl-CoA (purple) and OAA/NADH (gray), were analyzed.

These curves clearly demonstrate how the NADH/NAD⁺ ratio affects the activity of citrate synthase within a metabolon. NAD⁺ increases activity (Panel A) while NADH decreases it (Panel B).

Summary

(Summary written by Claude, Sonnet 4.6, Anthropic)

This chapter describes the multilayered regulatory mechanisms that govern the pyruvate dehydrogenase complex and the three primary control enzymes of the citric acid cycle — citrate synthase, isocitrate dehydrogenase, and α-ketoglutarate dehydrogenase — and introduces the concept of metabolon formation as an additional level of flux control.

The pyruvate dehydrogenase complex (PDC) sits at a critical metabolic junction, irreversibly committing pyruvate — the end product of glycolysis — to mitochondrial oxidation. Its regulation is correspondingly elaborate, integrating both allosteric and covalent mechanisms. Allosterically, PDC is activated by its substrates pyruvate and NAD⁺ (which signal available carbon and oxidizing equivalents, respectively) and by CoASH, and is inhibited by its products acetyl-CoA, NADH, and ATP — a straightforward product-inhibition logic that prevents continued oxidation when mitochondrial energy is already sufficient. The covalent layer involves two dedicated enzymes: pyruvate dehydrogenase kinase (PDK), which phosphorylates three serine residues (Ser264, Ser271, and Ser203) on the E1 α subunit, inactivating the complex, and pyruvate dehydrogenase phosphatase (PDP), which dephosphorylates and reactivates it. Phosphorylation at any single serine disrupts the ordering of the phosphorylation loop required for TPP binding and prevents productive engagement of the lipoyl domains of E2 with E1, thereby blocking the entire reaction sequence. PDK is itself activated by high acetyl-CoA, NADH, and ATP — the same signals that allosterically inhibit PDC — creating a coherent regulatory system. PDK is inhibited by dichloroacetate, pyruvate, Ca²⁺, and TPP; Ca²⁺ also activates the phosphatase PDP, linking PDC activity to muscle contraction and hormonal calcium signaling. At the hormonal level, insulin signaling promotes PDC dephosphorylation and activation, while starvation and diabetes enhance PDK activity and shift PDC toward the phosphorylated, inactive state, explaining why PDC deficiency causes lactic acidosis following carbohydrate ingestion and why a ketogenic diet — which bypasses glycolysis and provides acetyl-CoA directly from fatty acid oxidation — can compensate for this defect.

The citric acid cycle itself is regulated primarily through three enzymes chosen for their large negative ΔG°′ values and strategic positions: citrate synthase (step 1), isocitrate dehydrogenase (step 3), and α-ketoglutarate dehydrogenase (step 4). All three are sensitive to the mitochondrial NADH/NAD⁺ ratio — elevated NADH inhibits each — and to the ATP/ADP ratio, reflecting the principle that the cycle should slow when energy is abundant and accelerate when demand rises.

Citrate synthase is regulated by substrate availability (oxaloacetate and acetyl-CoA), by product inhibition from citrate (competitive with oxaloacetate) and CoASH, and by NADH (allosteric inhibitor in bacteria, less clearly in mammals) and succinyl-CoA (competitive with acetyl-CoA). The enzyme's open-to-closed conformational change upon oxaloacetate binding excludes water from the active site, preventing the spurious hydrolysis of acetyl-CoA that would otherwise occur.

Isocitrate dehydrogenase (IDH) is allosterically activated by citrate and ADP, which bind synergistically to the regulatory γ subunit of the α₂βγ mammalian complex. Citrate binding alone induces conformational changes — transmitted through the β5–β6 loop, α7 helix, and β7 strand at the heterodimer interface — that convert the isocitrate binding site from an inactive to an active conformation, reducing the S₀.₅ for isocitrate (the concentration required for half-maximal activity) and increasing catalytic efficiency. ADP binding does not itself cause further conformational change but stabilizes citrate binding through an extended hydrogen-bonding network involving Mg²⁺, synergistically amplifying the activation. Ca²⁺ also activates IDH by a distinct mechanism.

α-ketoglutarate dehydrogenase is regulated by mechanisms closely paralleling those of the PDC — product inhibition by succinyl-CoA (at E2) and NADH, inhibition by high ATP/ADP ratios, and activation by Ca²⁺. Of the three dehydrogenases regulated by Ca²⁺ (pyruvate, isocitrate, and α-ketoglutarate dehydrogenases), α-ketoglutarate dehydrogenase is the most sensitive, making it a particularly responsive link between mitochondrial calcium signaling and TCA cycle flux.

The chapter concludes with the concept of metabolon formation, in which three sequential cycle enzymes — malate dehydrogenase (MDH), citrate synthase (CS), and aconitase — assemble into a non-covalent multi-enzyme complex that enables direct substrate channeling. This is particularly important for oxaloacetate, which is present at very low steady-state concentrations and is the product of the thermodynamically unfavorable MDH reaction (ΔG°′ = +7.1 kcal/mol); channeling it directly to citrate synthase without releasing it into the bulk matrix effectively couples the unfavorable reaction to the highly favorable citrate synthase reaction. Electrostatic interactions between the positively charged Arg65 and Arg67 residues of CS and complementary surfaces on MDH drive complex formation. Crucially, the NADH/NAD⁺ ratio modulates the MDH-CS interaction: NAD⁺ (a substrate of MDH, signaling oxidized matrix) strengthens the metabolon, while NADH (signaling a reduced, energy-replete matrix) weakens it — providing an additional, systems-level mechanism by which the energy state of the mitochondria controls carbon flux through the citric acid cycle.